Brief: Memphasys Announces A$3.36 Mln Capital Raising To Accelerate Felix Commercialisation
17/08/2022 02:31
Aug 17 (Reuters) - Memphasys Ltd MEM.AX :
* A$3.36 MLN CAPITAL RAISING TO ACCELERATE FELIX
COMMERCIALISATION
Source text for Eikon: ID:nASX1ppd8Q
Further company coverage: MEM.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Memphasys
See all newsBrief: Memphasys Receives A$3.5 Million From Peters Investments
Brief: Memphasys Says Potential Expedited FDA Pathway To US IVF Market
Brief: Memphasys Secures 3-Year Felix Agreement With Invido For A$674,000 Minimum Purchases
Australia's Memphasys soars on signing exclusive commercialisation agreement with NOVIVITAE
Brief: Memphasys Says Vietnamese Registration For Felix System Has Been Achieved In August 2026